The partner companies we work with are critical to our success and never more so than when we select and cooperate with an IRT service provider. With a little careful thought and a positive internal approach our partnerships can be streamlined, efficient and rewarding for both sponsor and IRT vendor alike resulting in better IRT systems, built more speedily, at reduced cost and with a fraction of the customary frustration and duplication of effort.
In this session, you’ll learn:
- Appreciating the importance of positive vendor partnerships
- Developing a streamlined sponsor/vendor relationship
- A modern approach to UAT
- Best practices for UAT and beyond
About Our Speaker:
Kate Chapman, the Director of Clinical Technology Consultants Ltd. and the Principal Consultant, Clinical Technology Consultants, Winchester, UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.